| Bioactivity | ASPER-29 is Asperphenamate HY-129578 analog. ASPER-29 also is a dual cathepsin L and S inhibitor with IC50 value of 6.03 μM and 5.02 μM, respectively. ASPER-29 can be used for the research of the migration and invasion of cancer[1]. |
| Invitro | ASPER-29 具有双重 Cat L 和 S 抑制效力，IC50 值分别为 6.03 μM 和 5.02 μM[1]。ASPER-29 对胰腺癌 BxPC-3 和 PANC-1 细胞显示出明确的抗转移作用[1]。 |
| Name | ASPER-29 |
| CAS | 2630388-03-1 |
| Formula | C31H29BrN2O5S |
| Molar Mass | 621.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Haoqiang Huang, et al. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells. Bioorg Med Chem Lett. 2022 Nov 23;80:129087. |
ASPER-29
CAS: 2630388-03-1 F: C31H29BrN2O5S W: 621.54
ASPER-29 is Asperphenamate HY-129578 analog. ASPER-29 also is a dual cathepsin L and S inhibitor with IC50 value of 6.03
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.